Caas Capital Management LP Talaris Therapeutics, Inc. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.94 - $1.64 $195,074 - $340,342
-207,526 Reduced 69.71%
90,181 $91,000
Q3 2022

Nov 14, 2022
BUY
$2.3 - $5.03 $684,726 - $1.5 Million
297,707 New
297,707 $783,000
Q4 2021

Feb 14, 2022
SELL
$12.18 - $17.0 $152,164 - $212,381
-12,493 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$11.61 - $15.99 $899,856 - $1.24 Million
-77,507 Reduced 86.12%
12,493 $169,000
Q2 2021

Aug 16, 2021
BUY
$12.25 - $18.61 $1.1 Million - $1.67 Million
90,000 New
90,000 $1.32 Million

Others Institutions Holding TALS

# of Institutions
3
Shares Held
75.7K
Call Options Held
0
Put Options Held
0
View Full List

About Talaris Therapeutics, Inc.

TALS Quotes by TradingView
  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email